Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Canton Biotechnologies Inc
Profile last edited on: 2/17/22      CAGE: 5D0F4      UEI: LNADSW9GBR97

Business Identifier: Wound healing
Year Founded
2008
First Award
2010
Latest Award
2016
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

2601 Boston Street Suite 606
Baltimore, MD 21224
   (410) 342-0870
   N/A
   N/A
Location: Single
Congr. District: 03
County: Baltimore City

Public Profile

Canton Biotechnologies Inc operates as a specialty biopharmaceutical company. Based on wound healing biology that is well understood, the Company is a university-sponsored spin out to develop and commercialize high-value biotherapeutics that accelerates wound healing in acute and chronic wounds.

Extent of SBIR involvement

User Avatar
Phase I Awards
3
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$472,191
Phase II Dollars
$40,000
Total Awarded
$512,191

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2016 1 NIH $189,772
Project Title: Development of Iontophoresis Device for Plasmid DNA Transfection of Hypoxia Inducible Factor-1 to Improve Wound Healing
2012 1 DHA $149,343
Project Title: Engineering Functional Tissue for Repair and Regeneration
2010 1 NIH $173,076
Project Title: Improve Wound Healing with HIF-Ca5 DNA Vector and Electroporation

Key People / Management

  John W Harmon -- President

Company News

There are no news available.